Society ❯ Health Trends

Obesity

Weight Management Weight Loss Solutions Public Health Dietary Changes Weight Loss Medication Use Weight Loss Drugs Weight Loss Treatments Weight Loss Culture Dieting Medication Usage Prescription Drugs Heart Disease Pharmaceuticals GLP-1 Drugs Cultural Impact Workplace Wellness Childhood Obesity Dietary Habits Patient Access Diabetes Child Health Economic Impact Body Image Medication Access Chronic Diseases Lifestyle Choices Weight Loss Medications Lifestyle Changes Dieting Culture Binge Eating Consumer Behavior Pharmaceutical Industry Diet-Related Diseases Weight Loss Methods Consumer Choices Genetics Treatment Options

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

Regulators cited a head-to-head trial that showed about an 8% relative drop in major heart events versus Lilly’s older drug Trulicity, prompting wider use for high-risk adults with type 2 diabetes.

Bank of America Says It Pays Over $250 Million a Year for GLP‑1 Drugs

Novo Nordisk Asks Court to Halt Lilly’s National GLP‑1 Ads

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

Experimental Antibody Preserves Muscle During Tirzepatide Weight Loss

Cigna Drops GLP-1 Weight-Loss Coverage for Its Employees

Weight-Loss Pills Could Trim Airline Fuel Costs, Jefferies Says

WW International Raises 2025 Outlook on Clinical Momentum After Mixed Q3, Shares Jump

Costco Adds $499 Ozempic and Wegovy Offer Across U.S. Pharmacies

Florida Mom Delivers 13-Pound, 15-Ounce Baby Believed to Be a Hospital Record

Severe Maternal Obesity Linked to Increased Childhood Infection Hospital Admissions